307 related articles for article (PubMed ID: 31204103)
21. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
[TBL] [Abstract][Full Text] [Related]
23. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.
Wang LT; Pereira LS; Flores-Garcia Y; O'Connor J; Flynn BJ; Schön A; Hurlburt NK; Dillon M; Yang ASP; Fabra-García A; Idris AH; Mayer BT; Gerber MW; Gottardo R; Mason RD; Cavett N; Ballard RB; Kisalu NK; Molina-Cruz A; Nelson J; Vistein R; Barillas-Mury C; Amino R; Baker D; King NP; Sauerwein RW; Pancera M; Cockburn IA; Zavala F; Francica JR; Seder RA
Immunity; 2020 Oct; 53(4):733-744.e8. PubMed ID: 32946741
[TBL] [Abstract][Full Text] [Related]
24. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Willcox AC; Huber AS; Diouf A; Barrett JR; Silk SE; Pulido D; King LDW; Alanine DGW; Minassian AM; Diakite M; Draper SJ; Long CA; Miura K
Cell Rep Med; 2021 Jul; 2(7):100326. PubMed ID: 34337556
[TBL] [Abstract][Full Text] [Related]
25. PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47).
Nagaoka H; Sasaoka C; Yuguchi T; Kanoi BN; Ito D; Morita M; Udomsangpetch R; Sattabongkot J; Ishino T; Tsuboi T; Takashima E
Sci Rep; 2019 Apr; 9(1):5923. PubMed ID: 30976034
[TBL] [Abstract][Full Text] [Related]
26. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
Ragotte RJ; Higgins MK; Draper SJ
Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
[TBL] [Abstract][Full Text] [Related]
27. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
[TBL] [Abstract][Full Text] [Related]
28. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
[TBL] [Abstract][Full Text] [Related]
29. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.
Douglas AD; Baldeviano GC; Jin J; Miura K; Diouf A; Zenonos ZA; Ventocilla JA; Silk SE; Marshall JM; Alanine DGW; Wang C; Edwards NJ; Leiva KP; Gomez-Puerta LA; Lucas CM; Wright GJ; Long CA; Royal JM; Draper SJ
Nat Commun; 2019 Apr; 10(1):1953. PubMed ID: 31028254
[TBL] [Abstract][Full Text] [Related]
30. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
[TBL] [Abstract][Full Text] [Related]
31. Antibodies and Plasmodium falciparum merozoites.
Ramasamy R; Ramasamy M; Yasawardena S
Trends Parasitol; 2001 Apr; 17(4):194-7. PubMed ID: 11282510
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
33. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
34. Heterotypic interactions drive antibody synergy against a malaria vaccine candidate.
Ragotte RJ; Pulido D; Lias AM; Quinkert D; Alanine DGW; Jamwal A; Davies H; Nacer A; Lowe ED; Grime GW; Illingworth JJ; Donat RF; Garman EF; Bowyer PW; Higgins MK; Draper SJ
Nat Commun; 2022 Feb; 13(1):933. PubMed ID: 35177602
[TBL] [Abstract][Full Text] [Related]
35. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
36. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
Payne RO; Silk SE; Elias SC; Miura K; Diouf A; Galaway F; de Graaf H; Brendish NJ; Poulton ID; Griffiths OJ; Edwards NJ; Jin J; Labbé GM; Alanine DG; Siani L; Di Marco S; Roberts R; Green N; Berrie E; Ishizuka AS; Nielsen CM; Bardelli M; Partey FD; Ofori MF; Barfod L; Wambua J; Murungi LM; Osier FH; Biswas S; McCarthy JS; Minassian AM; Ashfield R; Viebig NK; Nugent FL; Douglas AD; Vekemans J; Wright GJ; Faust SN; Hill AV; Long CA; Lawrie AM; Draper SJ
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093263
[TBL] [Abstract][Full Text] [Related]
37. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
[TBL] [Abstract][Full Text] [Related]
39. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
